MyFinsight
Home
Blog
About
Back
Cash Flow
Protagenic Therapeutics, Inc. new (PTIX)
Protagenic Therapeutics, Inc. new (PTIX)
source: myfinsight.com
Net increase in cash
-$944,298
Stock based
compensation
$67,012
Accounts payable
$50,173
Impairment of intangible
assets
$13,337
Depreciation expense
$8,312
Net cash used in
operating activities
-$944,298
Canceled cashflow
$138,834
Net income (loss)
-$963,616
Prepaid expenses
$110,478
Accrued liabilities
-$9,038
Back